Nextbio
| Company type | Private |
|---|---|
| Founded | California, United States (2004) |
| Founder | Saeid Akhtari Ilya Kupershmidt Mostafa Ronaghi |
| Headquarters | , |
Area served | Worldwide |
Key people | Saeid Akhtari (President & CEO) Ilya Kupershmidt (VP of Product Management) Dr. Satnam Alag (VP of Engineering) |
Number of employees | 75 |
| Website | www.nextbio.com |
NextBio is a privately owned software company[1] that provides a platform for drug companies and life science researchers to search, discover, and share knowledge across public and proprietary data. It was co-founded by Saeid Akhtari, Ilya Kupershmidt, and Mostafa Ronaghi in 2004, and based in Cupertino, California, United States.
The NextBio Platform is an ontology-based semantic framework that connects highly heterogeneous data and textual information. The semantic framework is based on gene, tissue, disease, and compound ontologies. This framework contains information from different organisms, platforms, data types. and research areas that is integrated into and correlated within a single searchable environment using proprietary algorithms. It provides a unified interface for researchers to formulate and test new hypotheses across vast collections of experimental data.[2]
According to the company, the enterprise version of the NextBio platform is being used in life science research and development and drug development by researchers and clinicians at: Merck Pharmaceutical, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Celgene, Genzyme, Eli Lilly and Company, and Regeneron Pharmaceuticals.[3] This enterprise version allows internal, proprietary data to be uploaded and integrated into the NextBio database of publicly available data.[4] According to the company, scientists are using NextBio to improve their ability to identify relevant prognostic and predictive molecular signatures which are significant in their research.[5] In October 2013, Illumina acquired NextBio.[6] [7] In 2015, the NextBio research platform was rebranded as Correlation Engine.[8]
References
[edit ]- ^ Venture Beat, February 2007
- ^ "bio-itworld.com | 2007 Release: NextBio Life Science Search Engine Advances Systems Biology Approach to Research". Archived from the original on 2008年07月26日. Retrieved 2008年07月23日.
- ^ "Domain Inquiry". Markmonitor. Retrieved 2025年07月31日.
- ^ "Illumina FAQ". www.nextbio.com. Archived from the original on 2020年07月13日. Retrieved 2025年07月31日.
- ^ "NextBio". www.nextbio.com. Archived from the original on 2018年05月10日. Retrieved 2025年07月31日.
- ^ "Illumina Acquires NextBio in Deal Joining Sequencing, Big Data | GEN". GEN. 28 October 2013. Retrieved 2018年05月10日.
- ^ "Illumina to Acquire NextBio, Integrate Firm into Enterprise Informatics Business". GenomeWeb. Retrieved 2018年05月10日.
- ^ "Correlation Engine | Curated genomic data and mining tools". www.illumina.com. Retrieved 2024年06月13日.